End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
93,300 KRW | +4.25% | -6.79% | +37.61% |
2023 | ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2021 | ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility | CI |
ETFs positioned on ST Pharm Co.,Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.43% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 7 M€ | +5.94% | - | |
0.00% | 112 M€ | +4.44% | - | |
0.00% | 34 M€ | +4.49% | - |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.61% | 131.41Cr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 32TCr | |
+0.24% | 27TCr | |
+13.16% | 24TCr | |
+7.06% | 20TCr | |
-6.46% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |
- Stock Market
- Equities
- A237690 Stock
- Funds and ETFs ST Pharm Co.,Ltd.